BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/9/2024 1:59:13 PM | Browse: 103 | Download: 411
 |
Received |
|
2023-11-07 02:38 |
 |
Peer-Review Started |
|
2023-11-07 02:39 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2023-12-29 05:28 |
 |
Revised |
|
2024-01-08 15:15 |
 |
Second Decision |
|
2024-02-22 02:34 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-02-22 03:11 |
 |
Articles in Press |
|
2024-02-22 03:11 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2024-02-24 15:08 |
 |
Typeset the Manuscript |
|
2024-04-22 01:05 |
 |
Publish the Manuscript Online |
|
2024-05-09 13:59 |
ISSN |
1948-5204 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Oncology |
Manuscript Type |
Clinical and Translational Research |
Article Title |
Four centrosome-related genes to predict the prognosis and drug sensitivity of patients with colon cancer
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Hui-Yan Wang, Yan Diao, Pei-Zhu Tan and Huan Liang |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Heilongjiang Postdoctoral Fund |
LBH-Z18214 |
Haiyan Foundation of Harbin Medical University Cancer Hospital |
JJQN2014-06 |
Foundation of Health Commission of Heilongjiang province |
2016-096 |
|
Corresponding Author |
Huan Liang, MD, Associate Chief Physician, Department of Clinical Laboratory, Harbin Medical University Cancer Hospital, No. 150 Haping Road, Nangang District, Harbin 150086, Heilongjiang Province, China. 601774@hrbmu.edu.cn |
Key Words |
Colon cancer; Centrosome; Signature; Prognostic; Immune microenvironment; Therapy |
Core Tip |
Centrosome abnormalities, as the main microtubule tissue center of animal cells, are associated with human colon cancer. Our aim is to investigate the role of centrosome related genes (CRGs) in colon cancer. A total of 726 CRGs were collected from the public database. We constructed a centrosome-related signature composed of four genes: TSC1, AXIN2, COPS7A, and MTUS1. Colon cancer patients with high-risk characteristics have a low survival rate. Patients with high-risk characteristics exhibit decreased plasma cell levels and memory CD4+ T cell activation. Regarding treatment response, patients with high-risk characteristics are resistant to immunotherapy, chemotherapy, and targeted therapy. The expression of COPS7A is relatively high in endothelial cells and fibroblasts. MTUS1 is highly expressed in endothelial cells, fibroblasts, and malignant cells. We have constructed a prognostic marker related to centrosome, which can accurately predict the prognosis of colon cancer patients and contribute to the development of individualized colon cancer treatment. |
Publish Date |
2024-05-09 13:59 |
Citation |
Wang HY, Diao Y, Tan PZ, Liang H. Four centrosome-related genes to predict the prognosis and drug sensitivity of patients with colon cancer. World J Gastrointest Oncol 2024; 16(5): 1908-1924 |
URL |
https://www.wjgnet.com/1948-5204/full/v16/i5/1908.htm |
DOI |
10.4251/wjgo.v16.i5.1908 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345